Cellular Reprogramming Using Defined Factors and MicroRNAs

Takanori Eguchi,Takuo Kuboki

DOI: https://doi.org/10.1155/2016/7530942

2016-01-01

Stem Cells International

Abstract:Development of human bodies, organs, and tissues contains numerous steps of cellular differentiation including an initial zygote, embryonic stem (ES) cells, three germ layers, and multiple expertized lineages of cells. Induced pluripotent stem (iPS) cells have been recently developed using defined reprogramming factors such as Nanog, Klf5, Oct3/4 (Pou5f1), Sox2, and Myc. This outstanding innovation is largely changing life science and medicine. Methods of direct reprogramming of cells into myocytes, neurons, chondrocytes, and osteoblasts have been further developed using modified combination of factors such as N-myc, L-myc, Sox9, and microRNAs in defined cell/tissue culture conditions. Mesenchymal stem cells (MSCs) and dental pulp stem cells (DPSCs) are also emerging multipotent stem cells with particular microRNA expression signatures. It was shown that miRNA-720 had a role in cellular reprogramming through targeting the pluripotency factor Nanog and induction of DNA methyltransferases (DNMTs). This review reports histories, topics, and idea of cellular reprogramming.

cell & tissue engineering

What problem does this paper attempt to address?

The problems that this paper attempts to solve are several key issues in the field of cell reprogramming, which are as follows:

1. **Basic concepts and development history of cell reprogramming**:
- The paper first introduces the concept of cell reprogramming, especially the development of induced pluripotent stem cells (iPSCs). iPSCs are pluripotent stem cells induced from somatic cells (such as skin cells) by specific reprogramming factors (such as Nanog, Klf5, Oct3/4 (Pou5f1), Sox2 and Myc). This innovation has greatly changed the fields of life sciences and medicine.

2. **Methods and techniques of direct reprogramming**:
- The paper discusses the development of direct reprogramming techniques, that is, under specific conditions, using modified factor combinations (such as N - myc, L - myc, Sox9 and microRNAs) to directly reprogram cells into another type of differentiated cells (such as muscle cells, neurons, chondrocytes and osteoblasts). These methods have important application potential in regenerative medicine and disease modeling.

3. **The role of microRNAs in cell reprogramming**:
- The paper explores in detail the important role of microRNAs (such as miR - 302/367 cluster) in cell reprogramming. For example, the miR - 302/367 cluster promotes mesenchymal - epithelial transition (MET) by targeting the TGF - β signaling pathway and enhancing E - cadherin expression, thereby improving the reprogramming efficiency. In addition, the miR - 200 family further supports cell reprogramming by inhibiting the Zeb1 transcription factor and reducing the EMT process.

4. **Clinical application prospects**:
- The paper also discusses the potential of iPSCs and other pluripotent stem cells in clinical applications, especially in regenerative medicine and disease modeling. For example, iPSCs can be used to generate patient - specific disease models for drug screening and treatment research. In addition, iPSCs also show great potential in the treatment of diseases such as ophthalmology, spinal cord injury and diabetes.

In summary, this paper aims to comprehensively review and summarize the latest progress in the field of cell reprogramming, especially the generation and application of iPSCs, and the key role of microRNAs in this process. Through these studies, scientists hope to further promote the development of cell reprogramming technology and provide new tools and methods for future medical applications.